Immunologic checkpoint blockade with antibodies against the programmed cell death protein-1 (PD-1) or its ligand (PD-L1) is an effective method for reversing cancer immunosuppression and thereby ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

“This review shows that any primary, secondary or tertiary cause of death attributable to sickle cell trait is not a diagnosis substantiated by the medical evidence.” Approximately 300 million ...

Accumulating evidence indicates that DUBs also have the critical influence on anticancer immunity, simply by stabilizing pivotal checkpoints or key regulators of T-cell functions. Therefore, this ...

New research highlights the potential of the novel diagnostic tool iFRET to determine immunotherapy outcomes in stage 2 ...

Tislelizumab is BeiGene’s programmed cell death protein 1 (PD-1) checkpoint inhibitor and Anktiva is an interleukin-15 (IL-15 ...

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer ...

The antiviral capacity of both T cells and NK cells depends on complex crosstalk within the liver microenvironment, and the expression of immune checkpoint molecules (ICMs) plays a critical role. The ...

No scientific link found between sickle cell trait and sudden death. ScienceDaily . Retrieved February 7, 2025 from www.sciencedaily.com / releases / 2025 / 01 / 250130135535.htm ...

The Jacksonville Sheriff’s Office warned drivers to drive safe and sober on Sunday as they return home from Super Bowl festivities.

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...